(Q38013990)

27 August 2017

title

Paediatric and adult malignant glioma: close relatives or distant cousins? (English)

1 reference

27 August 2017

3

1 reference

27 August 2017

Chris Jones

1

0 references

author name string

Lara Perryman

series ordinal

2

1 reference

27 August 2017

language of work or name

English

0 references

publication date

29 May 2012

1 reference

Nature Reviews Clinical Oncology

27 August 2017

published in

1 reference

27 August 2017

volume

9

1 reference

27 August 2017

issue

7

1 reference

27 August 2017

page(s)

400-413

1 reference

The 2007 WHO classification of tumours of the central nervous system

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Grading of astrocytomas. A simple and reproducible method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Limitations of the World Health Organization classification of childhood supratentorial astrocytic tumors. Children Brain Tumor Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Prognostic limitations of the Daumas-Duport grading scheme in childhood supratentorial astroglial tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Neuropathological and neuroradiological spectrum of pediatric malignant gliomas: correlation with outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Age-incidence patterns of primary CNS tumors in children, adolescents, and adults in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Characterization and outcomes of infratentorial malignant glioma: a population-based study using the Surveillance Epidemiology and End-Results database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Guidelines on management of low-grade gliomas: report of an EFNS-EANO Task Force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Clinical and molecular characteristics of malignant transformation of low-grade glioma in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the Surveillance, Epidemiology, and End Results database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Diffuse brainstem glioma in children: critical review of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Thalamic high-grade gliomas in children: a distinct clinical subset?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Subpopulations of malignant gliomas in pediatric patients: analysis of the HIT-GBM database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Pediatric high grade glioma of the spinal cord: results of the HIT-GBM database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

A distinct spectrum of copy number aberrations in pediatric high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Genome-wide profiling using single-nucleotide polymorphism arrays identifies novel chromosomal imbalances in pediatric glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Genome-wide allelic imbalance analysis of pediatric gliomas by single nucleotide polymorphic allele array.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Cross-species genomics matches driver mutations and cell compartments to model ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Malignant gliomas with primitive neuroectodermal tumor-like components: a clinicopathologic and genetic study of 53 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

An integrated genomic analysis of human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

EGFRvIII deletion mutations in pediatric high-grade glioma and response to targeted therapy in pediatric glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Innovative Therapies for Children with Cancer pediatric phase I study of erlotinib in brainstem glioma and relapsing/refractory brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Genetic alterations in pediatric high-grade astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Molecular pathogenesis of pediatric astrocytic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Pediatric glioblastomas: a histopathological and molecular genetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Tyrosine kinase expression in pediatric high grade astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Gene expression profiling from formalin-fixed paraffin-embedded tumors of pediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Expression of p53 and prognosis in children with malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

IDH1 and IDH2 mutations in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

The genetic landscape of the childhood cancer medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Targeted therapy for BRAFV600E malignant astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Prospective study of awake craniotomy used routinely and nonselectively for supratentorial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Genomic aberrations in pediatric diffuse intrinsic pontine gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Critical oncogenic mutations in newly diagnosed pediatric diffuse intrinsic pontine glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Subtypes of medulloblastoma have distinct developmental origins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Mosaic analysis with double markers reveals tumor cell of origin in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Reversing HOXA9 oncogene activation by PI3K inhibition: epigenetic mechanism and prognostic significance in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Pontine glioma. To biopsy or not to biopsy: that is the question.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Diffuse intrinsic pontine glioma (DIPG): time to biopsy again?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

The role of hypofractionation radiotherapy for diffuse intrinsic brainstem glioma in children: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Changing paradigms--an update on the multidisciplinary management of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Chemotherapy for high-grade gliomas of childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Chemotherapy for high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

The influence of central review on outcome associations in childhood malignant gliomas: results from the CCG-945 experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Outcome of children treated with preradiation chemotherapy for a high-grade glioma: results of a French Society of Pediatric Oncology (SFOP) Pilot Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Pathologist interobserver variability of histologic features in childhood brain tumors: results from the CCG-945 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Receptor tyrosine kinase genes amplified in glioblastoma exhibit a mutual exclusivity in variable proportions reflective of individual tumor heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Enhanced efficacy of IGF1R inhibition in pediatric glioblastoma by combinatorial targeting of PDGFRα/β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Antiangiogenic agents for the treatment of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Signal transduction inhibitors and antiangiogenic therapies for malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Pediatric high-grade glioma: identification of poly(ADP-ribose) polymerase as a potential therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Immunotherapy for the treatment of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Novel delivery strategies for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Capturing the molecular and biological diversity of high-grade astrocytoma in genetically engineered mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

The use of immortalized cell lines in GPCR screening: the good, bad and ugly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Molecular characterization of the pediatric preclinical testing panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Direct orthotopic transplantation of fresh surgical specimen preserves CD133+ tumor cells in clinically relevant mouse models of medulloblastoma and glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Cancer stem cells in nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Clinical relevance of tumor cells with stem-like properties in pediatric brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

The pediatric preclinical testing program: description of models and early testing results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Combination testing (Stage 2) of the Anti-IGF-1 receptor antibody IMC-A12 with rapamycin by the pediatric preclinical testing program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Combination testing of cediranib (AZD2171) against childhood cancer models by the pediatric preclinical testing program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Diffuse glioma growth: a guerilla war

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Monitoring of tumor growth and post-irradiation recurrence in a diffuse intrinsic pontine glioma mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

A human brainstem glioma xenograft model enabled for bioluminescence imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Genetic modeling of gliomas in mice: new tools to tackle old problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Non-germline genetically engineered mouse models for translational cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Cooperativity within and among Pten, p53, and Rb pathways induces high-grade astrocytoma in adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Treatment of recurrent malignant supratentorial gliomas with carboplatin (CBDCA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Cisplatin in the treatment of recurrent childhood primary brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

PCNU and recurrent childhood brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Recurrent brainstem gliomas treated with oral VP-16.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Recurrent supratentorial malignant gliomas in children. Long-term salvage therapy with oral etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Phase II study of ifosfamide with mesna in adult patients with recurrent diffuse astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Phase II study of ifosfamide in childhood brain tumors: a report by the French Society of Pediatric Oncology (SFOP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Irinotecan therapy in adults with recurrent or progressive malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors: a report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Phase II trial of temozolomide in children with recurrent high-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Small molecule kinase inhibitors in glioblastoma: a systematic review of clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Phase I and pharmacokinetic studies of erlotinib administered concurrently with radiotherapy for children, adolescents, and young adults with high-grade glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

A phase I and biology study of gefitinib and radiation in children with newly diagnosed brain stem gliomas or supratentorial malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Nimotuzumab for pediatric diffuse intrinsic pontine gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Nimotuzumab in pediatric glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: a Pediatric Brain Tumor Consortium report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

A Canadian paediatric brain tumour consortium (CPBTC) phase II molecularly targeted study of imatinib in recurrent and refractory paediatric central nervous system tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Lack of efficacy of bevacizumab plus irinotecan in children with recurrent malignant glioma and diffuse brainstem glioma: a Pediatric Brain Tumor Consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Phase II trial of temsirolimus in children with high-grade glioma, neuroblastoma and rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Phase I trial of tipifarnib in children with newly diagnosed intrinsic diffuse brainstem glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Prognostic factors for high-grade malignant glioma: development of a prognostic index. A Report of the Medical Research Council Brain Tumour Working Party

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Childrens Cancer Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

The treatment of malignant brain tumors in infants and very young children: an update of the Pediatric Oncology Group experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2012.87

Nitrosourea chemotherapy for primary malignant gliomas.

31 March 2020

1 reference

12 December 2020

Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group study

1 reference

12 December 2020

Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: the past decade and where we are heading

1 reference

12 December 2020

5-[3,3-Bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196) in the treatment of childhood malignancy

1 reference

12 December 2020

Determination of p53 mutations, EGFR overexpression, and loss of p16 expression in pediatric glioblastomas.

1 reference

12 December 2020

Brainstem gliomas--a clinicopathological study of 45 cases with p53 immunohistochemistry

1 reference

12 December 2020

Identification of a cancer stem cell in human brain tumors

1 reference

12 December 2020

Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort.

1 reference

12 December 2020

PCNU treatment for recurrent malignant gliomas.

1 reference

12 December 2020

Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience

1 reference

12 December 2020

Multivariate analysis of prognostic factors in pediatric and adult thalamic and brainstem tumors

1 reference

12 December 2020

Stereotactic biopsy of diffuse pontine lesions in children

1 reference

12 December 2020

The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood.

1 reference

12 December 2020

10.1038/NRCLINONC.2012.87

Identifiers

DOI

1 reference

27 August 2017

1 reference